Fertility News and Research

RSS

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Ferring Pharmaceuticals presented an interim study analysis indicating that MENOPUR® (menotropins for injection, USP) is effective in in vitro fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) antagonist. The results were presented in a poster at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21, 2009.

21 Oct 2009

Complimentary book for fertility patients placing first fertility cycle order

Village Fertility Pharmacy (www.villagefertilitypharmacy.com), a specialty pharmacy focused exclusively on infertility medications, is pleased to announce that, effectively immediately, fertility patients who place a fertility cycle order for the first time will receive a complimentary copy of Kristen Magnacca's award-winning book, "Love and Infertility: Strategies for Survival - Balancing Infertility, Marriage, and Life."

20 Oct 2009

IntegraMed America expands its Attain IVF treatment financing offerings

IntegraMed America, Inc., the nation’s leading manager of specialty outpatient healthcare facilities in the emerging, technology-focused medical niches of fertility and vein care, today announced that it has expanded its Attain™ IVF (In Vitro Fertilization) family of treatment financing offerings to include the Attain IVF Multi-Cycle Program.

20 Oct 2009

Testicular cancer survivors at risk of effective treatment

Testicular cancer survivors can face an increased risk of long-term illness, not because of the malignancy, but the highly effective treatment they receive, according to a study in the urology journal BJUI.

20 Oct 2009

Link between stress reduction and increase in pregancy rate established

Women who participated in a stress management program prior to or during their second IVF cycle had a 160 percent greater pregnancy rate than women who did not participate in a program, according to a study presented today at the American Society for Reproductive Medicine's 65th Annual Meeting.

20 Oct 2009

Rituxan drug effective for treating ANCA-associated vasculitis

Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy.

19 Oct 2009

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

19 Oct 2009

Overview of procedures and techniques used for embryo transfer under transvaginal ultrasound guidance

Fertility and reproductive specialists are invited to join a live, online chat event entitled, “Transvaginal Ultrasound Transfers” at www.CookARTLab.com. The

12 Oct 2009

Women who take fertility drugs are at greater risk to develop thyroid cancer

Women who take the most common fertility drugs, progesterone and clomiphene, are at a greater risk to develop thyroid cancer than those who don't, according to a study by the Institute of Cancer Epidemiology, Danish Cancer Society.

12 Oct 2009

INVO Bioscience announce the birth of the first baby conceived by the INVO procedure and INVOcell device

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced that on September 29, 2009 the birth of the first baby conceived by the INVO procedure and INVOcell device. The mother is a 40 year old Pakistan woman who had suffered from infertility for 16 years.

9 Oct 2009

Program on protecting and preserving reproductive health

Octomom ... Kate Gosselin ... the recent embryo mix-up case in Ohio ... all stories stemming from infertility treatments and making national headlines. But, much to the surprise of many, there are several types of infertility that are actually preventable - something starting to make headlines. That's why The American Fertility Association's infertility prevention education outreach program, Manicures & Martinis, continues to sweep the nation with its next stop in Beverly Hills.

9 Oct 2009

DuoFertility helps women to conceive naturally without IVF

One in six women in the UK have difficulties conceiving – a figure which is predicted to rise to one in three by 2020. Many women turn to costly, invasive fertility treatments such as IVF, which typically has a success rate of 20%. DuoFertility is a groundbreaking new fertility monitor which helps women to maximise their chances of conceiving naturally without resorting to fertility treatment.

9 Oct 2009

Medical tourism in Latin America requires regulation: University of Montreal researchers

Medical tourism in Latin America needs to be regulated to protect consumers, according to Universit- de Montr-al researchers. A new study published in the journal Developing World Bioethics argues that Argentinean fertility clinics are increasingly marketing themselves to international health care consumers: these clinics offer all-inclusive packages with fixed prices that feature airfare, accommodations, transfers, language interpreters and, of course, fertility treatments.

8 Oct 2009

Birth control pills may have an impact on choice of partners

There is no doubt that modern contraception has enabled women to have unprecedented control over their own fertility. However, is it possible that the use of oral contraceptives is interfering with a woman's ability to choose, compete for and retain her preferred mate?

8 Oct 2009

Vitrolife and Cellartis extend collaboration in stem cell research

Vitrolife has entered into a new 3-year collaboration agreement with Cellartis AB regarding the development of new products for the culture, handling and differentiation of stem cells. The agreement extends the previous collaboration between the companies.

8 Oct 2009

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Cleveland Clinic's Top 10 Medical Innovations for 2010 list features a wide range of new techniques and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

7 Oct 2009

Vitro Diagnostics' research reveals expanded uses of its fluorescent stem cells

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced completion of a research report concerning its fluorescent stem cells, http://www.vitrobiopharma.com/wp-content/uploads/2009/10/fluorescent-msc-10-3.pdf. This report revealed transfer of fluorescent to differentiated cells including chondrocytes, cells responsible for making cartilage.

7 Oct 2009

Repros announces results of its Androxal efficacy study for secondary hypogonadism

Repros Therapeutics Inc. today announced results from an exploratory, efficacy and safety study of its oral investigational product, enclomiphene citrate (Androxal®), in men with secondary hypogonadism who were receiving testosterone replacement treatment. Secondary hypogonadism is a deficiency state in which the male hormone testosterone goes below the normal range, even in aging men, due to inadequate stimulation of the testes by the pituitary.

7 Oct 2009

Few risks to babies born to parents who underwent cancer treatment in childhood: Study

Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment. For cancer survivors who can have children, two new studies led by researchers at Fred Hutchinson Cancer Research Center may help alleviate fears that their childhood disease will adversely impact their newborns.

3 Oct 2009

Role of gene that could influence fertility identified in mice

Virginia Commonwealth University researchers have identified the role of a gene in regulating molecular signals involved with ovarian follicle development, which may one day help shed light on some of the causes of fertility issues in humans.

3 Oct 2009

Fertility News and Research

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Complimentary book for fertility patients placing first fertility cycle order

IntegraMed America expands its Attain IVF treatment financing offerings

Testicular cancer survivors at risk of effective treatment

Link between stress reduction and increase in pregancy rate established

Rituxan drug effective for treating ANCA-associated vasculitis

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

Overview of procedures and techniques used for embryo transfer under transvaginal ultrasound guidance

Women who take fertility drugs are at greater risk to develop thyroid cancer

INVO Bioscience announce the birth of the first baby conceived by the INVO procedure and INVOcell device

Program on protecting and preserving reproductive health

DuoFertility helps women to conceive naturally without IVF

Medical tourism in Latin America requires regulation: University of Montreal researchers

Birth control pills may have an impact on choice of partners

Vitrolife and Cellartis extend collaboration in stem cell research

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Vitro Diagnostics' research reveals expanded uses of its fluorescent stem cells

Repros announces results of its Androxal efficacy study for secondary hypogonadism

Few risks to babies born to parents who underwent cancer treatment in childhood: Study

Role of gene that could influence fertility identified in mice

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News